In This Section

  
Past Keynote Speakers | Previous Annual Meeting Reports 

Past Keynote Speakers

The Chapter's annual meetings have consistently drawn a wide representation of the midwestern pharmacology community. The following is a list of the past keynote speakers.

  • June 26, 2015 | John Christman | The Ohio State University, Wexner Medical Center | Epigenetic Regulation of Macrophage Gene Expression in ARDS Associated with Severe Sepsis
       
  • June 13, 2014 | Duncan Stewart | Ottawa Hospital Research Institute, University of Ottawa | Stem cells: Current and Future Use in Pharmacology
       
  • June 14, 2013 | Chunxiang (Kevin) Zhang | Rush University | MicroRNAs in Cardiovascular Disease: Current Progress and Challenges
       
  • June 22, 2012 | Jeffrey Conn | Vanderbilt University | Multiple Modes of Efficacy and Stimulus Bias of Allosteric Modulators of GPCRs
       
  • June 10, 2011 | Robert Messing | Gallo Research Center, UCSF | PKC Regulation of Cys-loop Receptors in Alcohol and Nicotine Addiction
       
  • June 18, 2010 | Douglas R. Green | St. Jude Children's Hospital | How the Cells Die
       
  • June 19, 2009 | Carol A. Colton | Duke University Medical Center | Reassessing Chronic Neuroinflammation in Alzheimer's Disease
       
  • June 13, 2008 | Neal Benowitz | University of California San Francisco | Pharmacogenetics of Nicotine Addiction and Treatment
       
  • June 8, 2009 | Marina E. Wolf | Rosalind Franklin University of Medicine and Science | Learning to be Addicted: Role of Glutamate Receptor Trafficking
       
  • June 9, 2006 | Michael B. Sporn, M.D. | Dartmouth Medical Center | New Synthetic Ttriterpenoids and Rexinoids: Multifunctional Agents with Many Potential Clinical Applications, Both for Prevention and Treatment of Disease
       
  • June 17, 2005 | Rene Hen, Ph.D. | Center for Neurobiology and Behavior, Columbia University | The Requirement of Hippocampal Neurogenesis for the Behavioral and Physiologic Effects of Antidepressants
       
  • June 3, 2004 | David Holtzman, M.D., Ph.D. | Department of Neurology, Washington University, St. Louis | Potential Role of Amyloid-Beta Binding Molecules in the Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease
       
  • May 8, 2003 | Dr. Hal E. Broxmeyer | The Walther Oncology Center, Indiana University School of Medicine | The Biology and Therapeutics of Hematopoietic Stem Cells from Cord Blood and Mobilized Peripheral Blood
       
  • June 10, 2002 | Dr. Neil Granger | LSU Health Science Center, Shreveport | Adhesion of Blood Cells to Microvascular Endothelium: Mechanisms and Targets for Therapeutic Intervention
       
  • May 31, 2001 | Dr. Stephen Morse | Centers for Disease Control | Bioterrorism: Are We Prepared?
       
  • June 1, 2000 | Dr. Malcolm Cohen | NASA-Ames Research Center | Astrobiology and Space Travel: The Big Picture, and, Dr. Janice Voss | NASA-Johnson Space Center | Another Perspective of Research in Space
       
  • June 8, 1999 | Dr. Eugene Sun | Abbott Laboratories | ABT-378 and the Continuing Therapeutic Challenges of HIV
        
  • June 10, 1998 | Dr. Michael Williams | Abbott Laboratories | The Analgesic Frog: Serendipity in the Drug Discovery Process
       
  • June 3, 1997 | Dr. Philip Needleman | Searle Research and Development | The Road to a Better, No, a Much Better Aspirin
       
  • May 3, 1996 | Dr. Palmer Taylor | UC San Diego, School of Medicine | A Tale of Divergence in Specificity and Gene Expression at Two Cholinergic Sites
       
  • June 16, 1995 | Dr. Louis Ignarro | UCLA, Medical Center | The Physiologic Significance of the Nitric Oxide-Cyclic GMP Signal Transduction Pathway in Mammalian Cells
       
  • June 10, 1994 | Dr. Irwin Fridovich | Duke University Medical Center | What is the Matter with Oxygen?
       
  • May 7, 1993 | Dr. Ray Fuller | Lilly Research Laboratories | Pharmacology Careers in the Pharmaceutical Industry
       
  • May 15, 1992 | Dr. Keith Killam | UC Davis, School of Medicine | Through a Looking Glass—Pharmacologically
       
  • May 9, 1991 | Dr. A. M. Goldberg | Johns Hopkins University | Animal Use and Alternative
       
  • April 20, 1990 | Dr. Eric Shooter | Stanford University | Nerve Growth Factor—From Molecule to Memory
       
  • April 4, 1989 | Dr. Philip Needleman | Monsanto Corporation, Research and Development | Biochemical Pharmacology of Atriopeptin and Related Peptides
       
  • May 12, 1988 | Dr. Julius Axelrod | NIMH | Receptor-Mediated Activation of Phospholipase A2 via GTP Binding Proteins

Previous Annual Meeting Reports

Last Updated: August 23, 2017

Job Postings